Hi,
The company has already told us the trials are progressing well.
Why not , no adverse effect 67% Orr for people that have already failed Checkpoint .
What's not to like if you in that position.
I would imagine the Keynote will be last of the results released.
Aloha
- Forums
- ASX - By Stock
- VLA
- Gilead buys Kite Pharma for $11.9 BN
Gilead buys Kite Pharma for $11.9 BN, page-19
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online